217170-95-1
Chemical Structure
PD 175069
- CAS No.: 217170-95-1
- Formula:C32H49N3O3
- Molecular Weight:523.75
IUPAC Name: (S)-N-((S)-3-(4-(benzyloxy)phenyl)-1-(tert-butylamino)-1-oxopropan-2-yl)-2-(isopentyl(methyl)amino)-4-methylpentanamide
InChIKey: ORBIOMYKKPXZOT-VMPREFPWSA-N
SMILES: CC(C)CCN(C)[C@@H](CC(C)C)C(N[C@H](C(NC(C)(C)C)=O)CC1=CC=C(OCC2=CC=CC=C2)C=C1)=O
Biological Activity: PD 175069 is a potent and selective N-type calcium channel antagonist with an IC50 of 0.32 μM. PD 175069 is efficacious in an audiogenic seizure model using DBA/2 mice. PD 175069 can be used for research on neurological conditions such as neuropathic pain and stroke[1].
| Cat. No. | Nom du produit | Pureté | Description | Pricing | |||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
PD 175069 | PD 175069 is a potent and selective N-type calcium channel antagonist with an IC50 of 0.32 μM. PD 175069 is efficacious in an audiogenic seizure model using DBA/2 mice. PD 175069 can be used for research on neurological conditions such as neuropathic pain and stroke. | |||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
Keywords
